Podcasts about africa cdc

Send us Fan MailIn this episode of Neo News, Ben and Eli break down a troubling story in vaccine policy: an unsolicited $1.6 million CDC grant funding a Danish research group's trial in Guinea-Bissau, one designed to withhold or delay the hepatitis B birth dose from thousands of newborns in a country where the disease is highly endemic. They trace the ethical parallels to Tuskegee, the funding irregularities, and the pushback from the Africa CDC that halted the study. They also cover the clinical stakes clinicians face daily, including age-dependent chronicity and the real risks of a "safe" two-month delay. A candid, unfiltered conversation about advocating for evidence-based care when the evidence itself becomes politicized.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below.Enjoy!

The ongoing Ebola outbreak in the Democratic Republic of Congo and Uganda has become the third-largest on record. And while the regional response is more robust than it was during the largest outbreak, in 2014-2016, the U.S. has now largely divested from global health initiatives under President Trump. So it raises the question: What role should the U.S. play in global health? And how do we build systems that protect our collective health even as political winds change? Flora speaks with John Nkengasong, virologist and founder of the Africa CDC, about Ebola, what it took to curb HIV/AIDS, and how to make global health initiatives more resilient. Dr. Jessica Bartley is senior director of psychological services for the U.S. Olympic and Paralympic Committee. Guest:  Dr. John Nkengasong has led public health initiatives in the United States and across Africa for over 30 years. He is also the executive director for higher education, collaboratives, and special initiatives at the Mastercard Foundation. Other episodes you may enjoy: A virus hunter in Nigeria has thoughts on the Ebola outbreak Inside the Nebraska quarantine facility responding to hantavirus Transcripts for each episode are available within 1-3 days at sciencefriday.com. Subscribe to this podcast. Follow our show on Instagram, TikTok, Facebook, and Bluesky @scifri and sign up for our newsletters. Got a science question that's keeping you up at night? Call us: 877-472-4374 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this second episode of AIDS2060, Ben sits down with Dr Andrew Kambugu, Executive Director of the Infectious Disease Institute at Makere University in Kampala Uganda. They discuss the state of the clinical response to HIV in Africa, and Andrew sets out a research and implementation agenda that gives equal weight to HIV prevention, treatment and diagnosis. He compares it to floor cleaning: you have to switch the water off at its source and not rely exclusively on mopping water up on the floor. In other words, African solutions for African problems of an epidemic that we know how to treat but can't control rates of infection across the continent. 00:00 AIDS 2060 episode 2 intro 02:20 Three pillar overview 02:58 Prevention breakthroughs 04:19 Treatment momentum risks 06:00 Injectables and dual therapy 08:24 Integrating chronic care 10:12 Circumcision and ownership 14:07 Rethinking optimization 20:03 Africa led R & D 26:02 Africa CDC and AMA 27:42 Building Regulatory Capacity 28:21 Private Sector Momentum 29:37 Uganda Manufacturing Model 31:55 Academia Industry R&D 33:35 Africa Research Priorities 36:44 Biotech and Diagnostics 44:55 Funding and Innovation 49:51 Closing Thanks and Outro Check Out Ben's Substack: https://substack.com/@benplumley1 Join the Conversation! How do you see the future of global health unfolding? Share your thoughts in the comments! Subscribe & Stay Updated: Listen on Spotify, Apple Podcasts, or your favorite podcast platform. Watch on YouTube & subscribe for more in-depth global health.

Deadly twin earthquakes strike Venezuela, the U.S. Supreme Court allows President Trump to end protections for Syrians and Haitians, Taiwan's Legislative Speaker meets U.S. lawmakers amid a $14 billion arms deal, Africa CDC raises its Ebola funding needs to $1.4 billion, OpenAI debuts its 'jalapeño' AI chip, President Trump asks Congress for $87.6 billion, including $67 billion for the Iran war, a top U.S. Army European commander will leave his position early, Western Australia Police will review the interactions it had with Virginia Giuffre, Europe shatters temperature records amid a deadly heatwave, and a report suggests that 180,000 Canadians wait in Emergency Room visits for over 48 hours. Sources: Verity.News

« Nous avons besoin rapidement de 1,4 milliard de dollars pour lutter contre le virus Ebola », affirme sur RFI le docteur Jean Kaseya, en ligne depuis Kinshasa. Il est le directeur général d'Africa CDC, le Centre africain de contrôle et de prévention des maladies, et qui sort d'une réunion de travail avec les présidents du Congo Kinshasa et du Burundi. Mais d'abord, le médecin congolais s'exprime sur le cas de son confrère qui vient d'être testé positif à Ebola à son arrivée à Paris en provenance du Congo. Pourquoi l'a-t-on laissé monter dans un avion ?  RFI ​​​​​ : Après le premier cas d'Ebola identifié en France et donc hors d'Afrique, est ce qu'il y a un risque mondial pour la santé publique ? Jean Kaseya : Le risque zéro n'existe pas et lorsque nous avons déclaré cette épidémie le 15 mai, nous avions déjà dit que, si jamais cette dimension régionale et cette dimension concentrée de l'épidémie au niveau de l'Ituri n'étaient pas considérées, il y aurait des risques que d'autres pays soient affectés. Donc, vous nous dites aujourd'hui qu'il y a quand même un risque pour toute la planète, c'est ça ? Nous vous disons aujourd'hui qu'il y a un risque. C'est pourquoi nous disons très clairement que c'est la solidarité qui va nous permettre d'arrêter cette épidémie. Et nous avons, l'OMS et Africa CDC, produit un travail. Ce travail demande aujourd'hui que nous puissions investir les moyens nécessaires, aussi bien pour l'Afrique que pour les autres pays. Et je réitère que la fermeture des frontières n'est pas la solution. La solution, c'est de permettre à ce que nous puissions avoir les moyens de répondre à cette épidémie afin d'éviter que d'autres pays soient affectés. Donc, ce qui s'est passé avec ce médecin arrivé à Paris, c'est une alerte en fait pour toute la communauté internationale ? D'abord, laissez-moi remercier ce médecin. Laissez-moi remercier son organisation Alima d'avoir été proche du peuple meurtri de l'Ituri. Ce médecin a beaucoup d'expérience dans la gestion des épidémies passées. Il est anesthésiste réanimateur et il a été au front du 19 mai au 22 juin. Il a quitté l'Ituri le 19 juin et a transité par Kinshasa. Quand il a quitté Kinshasa le 22, il ne présentait pas de symptômes. Et je voudrais aussi rappeler que le gouvernement de la RDC a mis en place des dispositifs de détection dans les aéroports de Bunia et de Kinshasa, qui permettent de savoir qui a les signes. Donc, à l'heure actuelle, nous ne pouvons pas parler d'un quelconque manquement. Nous devons juste dire que les signes se sont manifestés quand il a atterri à Paris. Et effectivement, pour répondre à votre question, ce sont des signaux d'alerte. Si jamais les partenaires et les autres gouvernements donateurs ne viennent pas, ces signaux d'alerte risqueront malheureusement de se multiplier. L'OMS dit que la transmission de l'épidémie d'Ebola s'accélère. Est-ce à dire qu'on n'a pas encore atteint le pic de cette épidémie ? A l'heure actuelle, nous ne pouvons pas encore dire que nous avons atteint le pic de cette épidémie. C'est vrai qu'il y a beaucoup de succès en termes de personnes qui sont guéries. Il y a des succès en termes de mobilisations communautaires. On commence à sentir que, de plus en plus, les communautés croient au message qu'on leur donne. Mais ce qui est compliqué, ce qui ne peut pas nous permettre de dire qu'on a atteint le pic, c'est la situation humanitaire qui est sérieuse. Nous avons des camps de déplacés internes qui contiennent près d'un million de personnes, et l'accès à ces camps est difficile, alors que nous savons que l'épidémie est dans ces camps. Et ça, c'est dans les camps de déplacés d'Ituri ? Effectivement, c'est dans les camps de déplacés, c'est dans l'épicentre, à Mongbwalu. Et c'est là où nous devons multiplier les efforts. Aujourd'hui, lors de la réunion des chefs d'Etat que nous avons eue, le mardi 23 juin à Kinshasa, avec le président Tshisekedi et le président Ndayishimiye du Burundi, nous nous sommes dit que l'aspect humanitaire compte maintenant pour 70 % de la réponse. L'aspect sanitaire compte pour 30 %. Ça signifie quoi ? Si nous n'arrivons pas à résoudre l'aspect humanitaire, nous n'allons pas arrêter cette épidémie. Au G7 d'Évian, la semaine dernière, en France, les sept pays les plus riches du monde ont promis une forte mobilisation contre cette souche d'Ebola jusqu'à quelque deux milliards de dollars. Est-ce que vous y croyez ? J'attends de voir ça. Les effets d'annonce ne m'impressionnent plus. Et je le dis aux pays du G7. Et j'ai eu l'opportunité d'en parler avec les autorités françaises qui président le G7. J'ai dit aujourd'hui que nous avions un plan de réponse à 518 millions de dollars, mais pas plus de 180 à 200 millions sont concrètement arrivés. Ça, c'était le volet sanitaire. Mais nous venons aussi de réévaluer le volet humanitaire. Aujourd'hui, nous avons besoin de 1,4 milliards de dollars pour nous assurer que nous parviendrons à avoir accès aux camps. Je vous ai dit que ce sont des camps de près d'un million de personnes où des maladies viennent, mais auxquels nous n'avons pas accès. Et ces camps-là, pendant longtemps, ont été abandonnés. Les gens n'ont pas d'eau courante, les gens n'ont pas de nourriture, les gens n'ont pas de toit. Et maintenant nous venons pour leur dire qu'il y a une épidémie. Et ces gens nous disent : pourquoi vous venez maintenant ? Donc, ça signifie que nous devons assurer leurs besoins primaires. Nous devons démanteler certains de ces camps, et nous devons nous assurer que tout le monde a accès aux soins. Et cela va nécessiter 1.4 milliards. J'attends voir venir aujourd'hui pour qu'on réponde à cette urgence rapidement.   À lire aussiEbola en RDC: «Presque chaque épidémie a sa légende»

Declan Walsh, the acclaimed New York Times Africa correspondent, visited the hot zone of the Ebola outbreak in Ituri Province in the Democratic Republic of the Congo (DRC) from May 22 to June 12, the "perfect petri dish." How to explain the "enormous lag" in acknowledging the outbreak and responding to it? "It all boils down to two factors, conflict and gold."  Will the outbreak grow exponentially or burn out? Insecurity will dominate, but it is not at all certain how that is to be managed. Things have begun to go better in expanding testing and treatment capacities, while contact tracing lags, at just over 50%. There are worries that the outbreak is spreading already from Ituri into North Kivu province, potentially into areas controlled by the Allied Democratic Forces (ADF), the Uganda-origin Islamist armed group. Interest is rising inexorably in seeking a cease-fire, given the acute vulnerability of health and emergency assistance providers. The United States is now coming in strong with over $700m in investments, but on a parallel track, separate from the incident management mechanism run by WHO and the Africa CDC, which is stirring some tensions with Congolese authorities. The U.S. effort to create a treatment unit on a remote air base in Kenya has generated considerable protests and political challenges for Kenyan President Ruto.

Dr. Salim Abdool Karim, the renowned South African epidemiologist, chairs the Africa CDC Emergency Consultative Group. In that role, he just completed a visit to Bunia, capital of Ituri province in the Democratic Republic of Congo, site of the dangerous Ebola outbreak. His focus included laboratories, test centers, isolation units, along with PPE, safe, dignified burials, contact tracing, the WHO/Africa CDC Incident Management Team, and security challenges. The United States has made major commitments, but US experts and US-funded groups operate outside the IMT. The moment you arrive in Buria, it is very obvious you are inside a conflict zone. Care providers—true heroes—are rushing in. They are "fire fighters running into the fire."

In his weekly clinical update, Daniel Griffin and Vincent Racaniello express concern  about vaccine policy and ACIP, scaling back of the CDC's role in global public health, shingles vaccine and dementia, new screwworm cases, the Ebola outbreak in the Congo and Uganda and where the hantavirus outbreak began, before Dr. Griffin deep dives into the measles outbreak, recent statistics on RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, Virgina outbreak of measles, how to access and pay for Paxlovid, how more people were negatively impacted by influenza than COVID, discontinuing contact precautions for COVID, where to go for answers about long COVID-19, and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Today we filed a motion asking the First Circuit to expedite our appeal of the district court's order in the AAP lawsuit that left ACIP—the nation's vaccine advisory committee—without a quorum (X) CDC advisers drop decades-old universal hepatitis B birth dose recommendation, suggest blood testing after 1 dose (CIDRAP) HHS asks for expedited appeal of court ruling on US vaccine policy (CIDRAP) New Plan Scales Back C.D.C.'s Work on Diseases Abroad (NY Times) Zoster Vaccination and Dementia: Interpreting the Signal and Testing the Mechanisms (CID) Safety and Immunogenicity of 1 or 2 Additional Doses of the Adjuvanted Recombinant Zoster Vaccine Administered 5–6 Years After Primary Vaccination in Adults ≥50 Years (OFID) Dashboard SCREWWORM.Gov (USDA: Animal and Plant Health Inspection Service) CDC Activates Emergency Operations Center for New World Screwworm Response (CDC Newroom) Head-to-head comparison suggests flu was much more likely to lead to hospitalization than COVID last winter (CIDRAP) FDA Issues Emergency Use Authorization for Generic Over-the-Counter Drug to Treat New World Screwworm in Dogs and Cats (FDA) Fact Sheet: Emergency Use Authorization of Nitenpyram Tablets (nitenpyram) for New World Screwworm (NWS) (FDA) Ebola dashboard (ebola.fyi)  EBOLA:The Democratic Republic of the Congo, 2026 (WHO) Bundibugyo virus disease outbreak Democratic Republic of the Congo (WHO: Democratic Republic of Congo) Ebola Outbreak: Current Situation (CDC:Ebola) Big Ebola outbreak puts spotlight on little known virus (Science) Ebola outbreak spreads to crowded displacement camp in Congo (Reuters) Ebola outbreak in DR Congo expands into large displacement camp (CIDRAP) Congo Ebola outbreak may be worst ever, Africa CDC says (Reuters) Advocacy groups are urging the release of the monoclonal antibody MBP134 and any other requested investigational therapeutics (Citizen.org) Hantavirus dashboard (Hantavirus.up Hantavirus on board with Prof. Vincent Racaniello (microbeTV) How did the cruise ship hantavirus outbreak start? (Science) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) Big outbreak, bright lights…Measles Dashboard( South Carolina Department of Public Health) Utah measles outbreak response (Utah Department of Health and Human Services) UtahMeasles Dashboard (Utah Department of Health and Human Services) US measles cases continue to climb, especially in Virginia(CIDRAP) Measles (VDH: Virginia Department of Health) Tracking Measles Cases in the U.S. (Johns Hopkins) Measles vaccine recommendations from NYP (jpg) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles (CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts (ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Anguished Parents, Crying Doctors: Life Amid Utah's Measles Outbreak (Wired) Characteristics of Patients Hospitalized with Measles During an Outbreak — West Texas, January–March 2025 (CDC:MMWR) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) USrespiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Flu vaccine recommendations: Vaccines and Related Biological Products Advisory Committee March 12, 2026 Meeting Announcement (FDA) WHO updates all 3 viral strains to be included in fall flu shots (CIDRAP) FDA vaccine advisers recommend adding subclade K to fall shots (CIDRAP) Weekly surveillance report: clift notes (CDC FluView) Influenza Vaccine and Associated Infection and Death in California, 2024 to 2025 (JAMA Network OPEN) OPTION 2: XOFLUZA $50 Cash Pay Option (xofluza) RSV: Waste water scan for 11 pathogens (WastewaterSCan) Respiratory Diseases (Yale School of Public Health) USrespiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) Respiratory Diseases (Yale School of Public Health) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Seasonal influenza versus COVID-19 hospitalisation risk during the 2025–26 influenza season (LANCET: Infectious Diseases) Discontinuingcontact precautions for COVID-19: the science says its time (Infection Control and Hospital Epidemiology) 2024-2025 COVID-19 Vaccine and Major Adverse Cardiovascular Events Among US Veterans (JAMA Internal Medicine) Where to get pemgarda (Pemgarda) EUAfor the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) UnderstandingCoverageOptions (PAXCESS) Infectious Disease Society guidelines for treatment and management (ID Society) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulation guidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia University Irving Medical Center) The answers: Long COVID Reaching out to US house representative Letters read on TWiV 1332 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

This week, Chris Dall and Dr. Michael Osterholm bring the latest on the Ebola outbreak in the DRC, what the World Cup means from a public health perspective, as well as explain what screwworm is and how it could threaten US livestock. They'll also have updates on the hantavirus outbreak, discuss how the US could likely lose its measles elimination status, and give you an update on COVID and other respiratory infections. Plus, the latest installment of This Week in Public Health History.  Links:The ‘diseases of crowds' experts say could be at the World Cup (CIDRAP) Africa CDC head warns Ebola outbreak could be worst ever (CIDRAP) 20 Years of HPV Vaccine Success (CIDRAP)  Resources for vaccine and public health advocacy: Voices for Vaccines Families Fighting Flu Vaccinate Your Family Shot@Life Medical Reserve Corps Learn more about the Vaccine Integrity Project MORE EPISODES       SUPPORT THIS PODCAST   Music: "Beauty Flow" Kevin MacLeod (incompetech.com)Licensed under Creative Commons: By Attribution 4.0 License

Two years since the launch of the African Vaccine Manufacturing Accelerator (AVMA), a financial mechanism that invests in commercially viable manufacturing efforts on the continent, what progress has been made in the effort to produce 800 million vaccines in Africa by 2035? Where are there opportunities for strengthening access to routine immunizations for vulnerable populations, including the 6.7 million zero-dose children in the region, along with those living in fragile and conflict-affected areas? And how can the AVMA, which was developed in response to the region's challenges in securing access to Covid-19 vaccines during the global pandemic, help build countries' resilience in the face of current and future disease outbreaks? Please join the CSIS Bipartisan Alliance for Global Health Security for a broadcast conversation with Katherine E. Bliss, Director and Senior Fellow, Immunizations and Health Systems Resilience, with the CSIS Global Health Policy Center, Farrah Losper, Chief Commercial Officer at Biovac and Chairperson of the Board of the African Vaccine Manufacturing Initiative, Folake Olayinka, Director of Immunization, Africa CDC, Shanelle Hall, Principal Advisor to the Director General, Africa CDC, and David Kinder, Head of Development Finance at Gavi, the Vaccine Alliance, regarding the progress of the AVMA and contributions to the immunization landscape in the Africa region. 

Can global health serve an increasingly fragmented world? That's the question Garry Aslanyan asks co-hosts  Catherine Kyobutungi and Ricardo Baptista Leite in the latest installment of “The Inside Track.” And this time, the trio is joined by special guest Tenu Avafia, Deputy Executive Director of Unitaid. Their conversation spans AI governance, geopolitics, and access to health. From the mismatch between how AI is built and who it's built for, to the normalization of hate eroding global solidarity, to the rise of regional institutions like Africa CDC and the African Medicines Agency — this episode maps a global health landscape genuinely at a crossroads. Related episode documents, transcripts and other information can be found on our website.Subscribe to the Global Health Matters podcast newsletter.  Follow us for updates:@TDRnews on XTDR on LinkedIn@ghm_podcast on Instagram@ghm-podcast.bsky.social on Bluesky  Disclaimer: The views, information, or opinions expressed during the Global Health Matters podcast series are solely those of the individuals involved and do not necessarily represent those of TDR or the World Health Organization.    All content © 2026 Global Health Matters.

Peter Power, Executive Director of UNICEF Ireland in Sierra Leone

Alors que l'épidémie d'Ebola continue d'affecter la République démocratique du Congo et la région des Grands Lacs, la riposte sanitaire et humanitaire s'organise, notamment avec l'aide de l'Union européenne qui a mis 170 millions d'euros sur la table. Le week-end dernier, la commissaire européenne à la coopération internationale, à l'aide humanitaire et à la réaction aux crises s'est rendu une nouvelle fois dans l'est du pays, à Bunia, l'épicentre de la maladie. Hadja Lahbib est la Grande Invitée Afrique de RFI.   RFI : Vous étiez à Bunia la semaine dernière dans l'épicentre de l'épidémie d'Ebola. Quels enseignements en tirez-vous sur la situation ? Hadja Lahbib : L'Union européenne est un partenaire fiable, loyal, fidèle à l'Afrique. Dès l'apparition de l'épidémie, on a envoyé 100 tonnes de matériel médical, de tentes, de protection personnelle pour les travailleurs humanitaires. Mais aller sur place, témoigner de sa solidarité, communiquer, voir comment aussi l'aide est distribuée, comment elle est mise en place, c'est autre chose. Et je crois que ça a été très bien reçu par les communautés en place. Et votre bilan concernant l'arrivée de l'aide et sa gestion sur place ? Tout d'abord, l'aide est bien parvenue, j'ai pu le constater moi-même. Le corridor Bukavu-Uvira est toujours ouvert. Une liaison aérienne humanitaire d'Entebbe à Bunia a été établie. Et donc pour les communautés qui sont actuellement touchées par cette épidémie d'Ebola, c'est extrêmement important car ça permet évidemment, grâce à l'ouverture de ces infrastructures logistiques, de faire parvenir l'aide au plus vite. C'est vraiment une ligne de vie. Et ensuite la communication : j'ai vu les infrastructures sanitaires mises en place. C'est très important. Il y a eu beaucoup de désinformation dans les communautés qui ont conduit malheureusement à des faits de violence. Vous savez que des tentes médicales ont été brûlées. Un hôpital a été attaqué parce qu'il y avait des rumeurs qui disaient que les corps étaient enlevés pour qu'on prélève, par exemple, les organes vitaux, etc. Donc on a pu installer des infrastructures transparentes qui permettent aux familles de garder un contact avec leurs proches quand ils sont suspectés d'avoir été contaminés ou qu'ils sont contaminés de façon avérée. Et donc ces parois transparentes permettent d'arrêter de nourrir les peurs fantasmagoriques et de rassurer les familles. Finalement, avoir des solutions africaines pour des problèmes africains, c'est ce qui est le plus important, avec bien sûr le soutien de l'Union européenne. Et ça, ce n'est possible que si les communautés, les populations locales sont dans une relation de confiance avec le corps médical et avec les ONG sur place. Il y a une semaine, le docteur congolais et prix Nobel de la paix, Denis Mukwege, écrivait dans le journal Le Monde que cette 17ᵉ épidémie d'Ebola en RDC pourrait devenir la plus meurtrière jamais enregistrée, notamment du fait que la souche Bundibugyo soit très rare. Vous qui étiez sur place, vous partagez ce constat alarmant ? La dernière épidémie, même si on n'en a pas parlé ici en Europe, elle date seulement d'il y a cinq mois. Ça montre la nécessité d'avoir une réponse durable. Ce qu'on a construit pour l'instant, ce sont des infrastructures qui ne sont pas pérennes. Or, vous le savez, à cause de la guerre qui sévit dans cette région de l'Ituri, entre autres, mais aussi de Goma, le système de santé est à genoux. On compte à peu près trois millions de déplacés dans toute la région. Rien que dans le Sud-Kivu, le Nord-Kivu et l'Ituri, c'est près d'un million de personnes déplacées. J'ai moi-même été dans les camps où des dizaines de milliers de personnes sont rassemblées, alors que le camp a une capacité seulement de la moitié ou voire d'un dixième, avec des conditions sanitaires extrêmement précaires. C'est comme si on était assis sur un volcan qui, à un moment ou un autre, va exploser. Donc il est essentiel d'avoir une approche durable, d'avoir un cessez-le-feu aussi qui soit respecté par toutes les parties prenantes au conflit et de cesser aussi des déforestations sauvages, des exploitations sauvages des mines de matériaux critiques qui, finalement, retranchent les animaux sauvages qui deviennent contagieux, car vous savez que ces zoonotiques, c'est une maladie transmise par les chauves-souris, qui est le résultat de la dégradation du milieu naturel. Parlons du rôle des États-Unis. Il y a la construction très controversée d'un centre d'accueil Ebola au Kenya, voulu par les Américains et contesté par les populations sur place, alors que le Kenya est épargné par le virus. Washington exige également de la part de votre pays, la Belgique, de ne plus accueillir sur son sol des ressortissants congolais et de pays touchés par Ebola. Comment l'Europe fait-elle face aux pressions de Washington sur la gestion de ses propres frontières ? L'Europe a une approche basée sur l'expertise scientifique. Nous avons créé, suite au Covid-19 et la pandémie, la Haute autorité pour la réponse aux épidémies. Nous monitorons tous les virus qui circulent, par exemple dans les eaux usées. Nous avons boosté la recherche scientifique. Nous avons aussi notre propre centre de contrôle des maladies infectieuses. Nous collaborons main dans la main avec Africa CDC, qui est notre partenaire sur place. Les États-Unis, eux, ont une toute autre approche American First. Nous Européens, nous avons plutôt une approche qui vise à soutenir une réponse africaine pour une urgence africaine, mais aussi internationale.

The Africa CD and the WHO say 34 health workers have been infected with the Ebola virus so far, and seven of them have died. The two institutions have launched a plan, aiming to raise 518 million U.S. dollars to support African countries to respond to the outbreak.

On this episode of Today in Global Health, Professor Ngwaba and Oluwakayode tackle one of the most significant public health stories on the continent — the ongoing outbreak of the rare Bundibugyo strain of Ebola in the Democratic Republic of the Congo and Uganda.The discussion breaks down why this outbreak has triggered a global alarm, with the World Health Organization declaring it a Public Health Emergency of International Concern and the Africa CDC designating it a continental security emergency.Professor Ngwaba explains the unique danger posed by the Bundibugyo strain, particularly because there are currently no licensed vaccines or specific treatments available for it. The conversation examines the outbreak's spread across borders, the challenges facing health authorities, and why containment remains the most effective weapon against the disease.Closer to home, the episode explores what this means for Nigeria. Drawing lessons from the country's successful response to the 2014 Ebola outbreak, the discussion highlights the importance of airport surveillance, contact tracing, public awareness, emergency preparedness, and strengthening healthcare systems before a crisis arrives.Beyond the medical implications, the show examines how disease outbreaks affect economies, education, migration, governance, and regional stability. Professor Ngwaba also emphasizes the need for stronger African health institutions, local vaccine research capacity, and cross-border cooperation in managing future public health threats.Insightful, urgent, and deeply relevant, this episode serves as both a public health education session and a reminder that in an interconnected world, health security anywhere affects health security everywhere.

Neste programa Semana em África, voltamos à situação na RDC, a braços com a epidemia do ébola, e olhamos para as medidas que Angola começou a adoptar. Também olhamos para Cabo Delgado, onde a retoma do projecto da francesa Total gera críticas. Ainda em Moçambique, destacamos o estudo do CIP sobre o fecho de 500 empresas nos últimos dois anos. Quanto a Cabo Verde, o destaque vai para a Cimeira das Nações Crioulas. Começamos com a República Democrática do Congo, onde chegou, esta sexta-feira, o director da Organização Mundial de Saúde para tentar encontrar mais respostas para conter a epidemia de ébola. Recordo que, até ao final da semana, tinham sido registadas 246 mortes em mais de mil casos suspeitos, de acordo com um relatório do Centro Africano de Controlo e Prevenção de Doenças, a agência de saúde da União Africana. Também esta sexta-feira,foi confirmada uma recuperação, a primeira desde o início da epidemia. Entretanto, em Angola, as autoridades sanitárias intensificam as medidas de vigilância e prevenção contra o Ébola, sobretudo nas regiões fronteiriças com a República Democrática do Congo, devido ao índice de mortes provocado pela epidemia. A 23 de Maio, a agência de saúde Africa CDC alertou que Angola está entre os dez países africanos que correm o risco de ser afetados pelo vírus Ébola, além da RDC, epicentro da epidemia, e do Uganda. Um trabalho  de Francisco Paulo. Poucos meses depois de ter retomado o projecto moçambicano de gas natural liquefeito em Cabo Delgado, esta sexta-feira, a TotalEnergies reuniu-se em Paris para a sua assembleia-geral para apresentar lucros recorde. Daniel Ribeiro, da ong moçambicana Justiça Ambiental, denuncia que a situação em Cabo Delgado “continua perigosa e a insurgência activa”. Em Moçambique, um grupo de membros da Renamo submeteu à Procuradoria-Geral da República um documento com 18 mil assinaturas para impugnar a liderança de Ossufo Momade. O coordenador nacional da comissão de gestão do partido, Edgar Silva, pediu a Ossufo Momade que apresente contas. Em Moçambique, desde 2024, mais de 500 empresas fecharam e deixaram mais de 15 mil trabalhadores desempregados devido à escassez de divisas no país. A conclusão é do Centro de Integridade Pública que divulgou em Maputo um estudo sobre esta problemática, como explica a investigadora do CIP, Teresa Boene. Em Cabo Verde, arranca esta quinta-feira a Cimeira das Nações Crioulas, que decorre até ao dia 30 de Maio. Num contexto internacional marcado por guerras, intolerância e profundas desigualdades, o Presidente José Maria Neves defende que esta iniciativa pretende criar uma nova dinâmica de diálogo, assente na cooperação e na valorização das identidades crioulas. Em Cabo Verde, as mulheres representam menos de dois por cento da população prisional, mas a Comissão Nacional para os Direitos Humanos e a Cidadania alerta que esta realidade não pode esconder os desafios enfrentados pelas reclusas. A instituição defende medidas mais equitativas e condições mais dignas para o cumprimento das penas, sobretudo no contacto com os filhos menores. Odair Santos. Em São Tomé e Príncipe, a vice-presidente da ADI - Acção Democrática Independente -, Celmira Sacramento, anunciou na quarta-feira, em conferência de imprensa, que o partido apresentou uma queixa-crime no Ministério Público contra, nomeadamente, o primeiro-ministro Américo Ramos.

In eastern DRC, the battle against Ebola is being fought alongside ongoing conflict. As violence restricts access, fuels mistrust, and disrupts lifesaving care, health workers face a daunting challenge: containing a deadly virus in one of the world's most insecure regions. DW spoke to DRC's Foreign Minister, Therese Kayikwamba, and Jean Kaseya, Director General of Africa CDC.

Africa Melane speaks to Professor Helen Rees about a growing Ebola outbreak in the DRC and Uganda, where suspected cases and deaths are rising and a vaccine could still be up to nine months away. With experimental vaccines under consideration and South Africa pledging over R40 million to support the Africa CDC response, the discussion focuses on containment, urgency, and regional preparedness. Early Breakfast with Africa Melane is 702’s and CapeTalk’s early morning talk show. Experienced broadcaster Africa Melane brings you the early morning news, sports, business, and interviews politicians and analysts to help make sense of the world. He also enjoys chatting to guests in the lifestyle sphere and the Arts. All the interviews are podcasted for you to catch-up and listen. Thank you for listening to this podcast from Early Breakfast with Africa Melane For more about the show click https://buff.ly/XHry7eQ and find all the catch-up podcasts here https://buff.ly/XJ10LBU Listen live on weekdays between 04:00 and 06:00 (SA Time) to the Early Breakfast with Africa Melane broadcast on 702 https://buff.ly/gk3y0Kj and CapeTalk https://buff.ly/NnFM3N Subscribe to the 702 and CapeTalk daily and weekly newsletters https://buff.ly/v5mfetc Follow us on social media: 702 on Facebook: https://www.facebook.com/TalkRadio702 702 on TikTok: https://www.tiktok.com/@talkradio702 702 on Instagram: https://www.instagram.com/talkradio702/ 702 on X: https://x.com/Radio702 702 on YouTube: https://www.youtube.com/@radio702 CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567 See omnystudio.com/listener for privacy information.

The Africa Centers for Disease Control and Prevention has declared the Ebola outbreak in the Democratic Republic of the Congo and Uganda as a public health emergency of continental security.

Une nouvelle épidémie d'Ebola déclarée en République démocratique du Congo, dans la province de l'Ituri, ainsi que dans deux pays voisins, l'Ouganda et le Soudan du Sud. L'information a été confirmée par l'OMS et l'agence sanitaire de l'Union africaine, Africa CDC. Plusieurs dizaines de cas ont déjà été recensés et de nombreux décès enregistrés. La RDC reste le foyer principal de cette épidémie, et une nouvelle souche de contamination y a été découverte. Cette dernière, explique le Dr Jean Kaseya, épidémiologiste et directeur général du Centre africain de contrôle et de prévention des maladies (Africa CDC), ne dispose pour le moment ni de vaccin, ni de traitement. RFI : Le 5 mai 2026, l'Organisation mondiale de la santé a reçu un signal de cas suspects et a envoyé une équipe sur le terrain. Les premiers échantillons testés à Mungbwalu étaient négatifs. Ce n'est que le 15 mai que l'Institut national de recherche biomédicale a confirmé les cas positifs. Deux jours se sont écoulés. Ce délai a-t-il aggravé la situation ? Dr Jean Kaseya : On peut dire que tout délai dans une flambée d'Ebola est préoccupant, mais que les premiers échantillons négatifs ne suffisent pas à exclure une flambée. Cela peut dépendre du moment du prélèvement, de la qualité de l'échantillon, du choix des cas testés, du transport ou de la dynamique de transmission. Nous devons examiner la chronologie complète avant de conclure que ce délai a aggravé la situation. Ce que nous savons, c'est qu'Ebola exige une réponse immédiate dès le signal et cela signifie l'investigation, l'isolement, la recherche des contacts, le contrôle des infections et la communication communautaire. Voilà pourquoi Africa CDC travaille avec les gouvernements à accélérer la confirmation, à renforcer les laboratoires, à reconstituer les chaînes de transmission et à réduire tout nouveau délai opérationnel. Le patient zéro a-t-il été identifié ? Le patient zéro n'a pas été publiquement confirmé. À ce stade, les enquêtes épidémiologiques sont en cours pour établir la chronologie des premiers cas, les expositions possibles, les événements communautaires, les soins reçus. Vous savez, les funérailles et les déplacements sont aussi d'autres facteurs. Les informations venant de la communauté sont importantes et doivent être écoutées. Nos équipes travaillent avec le gouvernement et d'autres partenaires pour que nous puissions vérifier scientifiquement avant de parler du patient zéro. On parle de la RDC, mais d'autres pays seront également impactés, l'Ouganda et le Soudan du Sud notamment. Vous confirmez ? Effectivement, la situation est confirmée en Ouganda. On parle de la même souche qui vient d'être confirmée en RDC. Il s'agit de la souche « Bundibugyo » et on parle de cas importés en Ouganda venant de la RDC, dont une personne est déjà morte. Actuellement, nous sommes en train de travailler sur la détection rapide pour renforcer la surveillance. On est en train de rechercher les contacts, de faire de la prévention et le contrôle des infections. Nous avons aussi la communication avec les communautés, bien sûr, les enterrements sûrs et dignes au niveau du Soudan du Sud. Nous activons la pression maximale en termes de prévention et surtout de détection accélérée s'il y avait un cas. Pour revenir à la RDC, c'est la 17e épidémie que connaît le pays depuis 1976. Mais cette fois, ce n'est pas la souche Zaïre. Le séquençage est en cours. Vous avez évoqué tout à l'heure le nom de la nouvelle souche. Pouvez-vous nous rappeler de quelle souche il s'agit ? Généralement, nous parlons des trois souches. Il y en a une vingtaine, mais généralement on parle de trois souches pour Ebola : la souche « Zaïre », que l'on connaît, la souche « Soudan », et la souche « Bundibugyo ». C'est de celle-là dont on parle. Cette souche n'a pour le moment aucun vaccin disponible, aucun médicament disponible. Nous avons des vaccins candidats, des médicaments candidats sur lesquels nous sommes en train de travailler. Aujourd'hui (vendredi 15 mai, NDLR), mon équipe a eu une réunion avec tous les partenaires et les industriels pharmaceutiques qui ont des produits sur lesquels on fait des études, et donc nous saurons vous informer un peu plus dans les prochains jours. Dernière question, quelle est votre plus grande crainte dans les prochaines 72 heures ? La crainte des chaînes de transmission invisibles, des contacts qui ne sont pas listés, des personnes exposées qui se déplacent vers Bunia, vers l'Ouganda, vers le Soudan du Sud, des soignants qui sont exposés sans protection suffisante et surtout des décès communautaires sans enterrements. Les prochaines 72 heures doivent servir à passer d'un signal inquiétant à une réponse structurée, où nous allons lister les contacts. On va prendre des soins sécurisés, on va renforcer les laboratoires et on va avoir des communautés informées. À ce moment-là, je peux commencer à dire que nous pourrions contrôler cette épidémie dans les semaines qui viennent. À lire aussiRDC: nouvelle épidémie d'Ebola en cours en Ituri, la société civile appelle à éviter le pire

COVID-19, Africa, health preparedness, pandemic response, vaccine production, health financing, regional collaboration, conflict resolution, health systems, infectious diseases, ghost workers, corruption, inefficienciesIn this conversation, Dr. Jean Kaseya, Director General of Africa's Centres for Disease Control and Prevention (CDC), discusses the impact of COVID-19 on the continent. He emphasises the continent's need for improved health preparedness and self-sufficiency. He outlines five key pillars for pandemic preparedness, including health financing, local manufacturing, and digital health initiatives. We also cover the importance of regional collaboration, innovative financing strategies, and the intersection of health and conflict resolution. Dr. Kaseya highlights lessons learned from the pandemic and the necessity of being prepared for future outbreaks, while also addressing the challenges posed by infectious diseases in Africa.Takeaways:*Preparedness is essential for national and global security.*Africa must increase health financing and reduce inefficiencies. *Local manufacturing of health products is crucial for self-sufficiency.*Innovative financing methods can enhance health budgets.*Vaccine nationalism highlighted Africa's dependency on external supplies.*Regional collaboration is vital for effective health responses.*Health outcomes are linked to conflict resolution efforts.*Lessons from COVID-19 inform future health strategies.*The next pandemic is likely to be zoonotic and influenced by climate change.*Addressing infectious diseases requires a multifaceted approach.Chapters00:00Assessing Africa's COVID-19 Experience03:05Pillars of Pandemic Preparedness06:01Innovative Financing for Health08:52Local Vaccine Production and Technology Transfer11:53Regional Collaboration in Health14:51Health and Conflict Resolution17:57Lessons Learned from COVID-1920:49Preparing for Future Pandemics24:11Progress and Challenges in Health Systems27:03Addressing Infectious Disease Outbreaks Hosted on Acast. See acast.com/privacy for more information.

Soon after USAID was closed in February, speculation circulated that China would move quickly to fill the void left by the United States. That did not happen. While the Chinese did step in to provide modest additional funding for a handful of programs, like demining initiatives in Cambodia and support for the Africa CDC in Addis Ababa, overall, there's been no significant change in China's foreign aid programs. That did not surprise Alicia Chen, a PhD candidate at Stanford University, who noted in a recent Foreign Affairs article that Beijing is very tactical with where and how it distributes overseas development assistance. Alicia joins Eric to discuss Beijing's foreign aid strategy and how it differs from other major donors.

This Podcast features both co-chairs of first-ever World Health Organization (WHO) Task Force on Antimicrobial Resistance (AMR): Katherine Urbaez and Tracie Muraya.Katherine Urbaez is a former diplomat from the Dominican Republic, who has been instrumental throughout her career in numerous negotiations and in developing public policies within various multilateral processes, with a specific focus on health, human rights, and environmental issues. She also served on the Executive Board Membership to WHO.Tracie Muraya is the Deputy Director for Policy & Strategy for ReAct Africa. She engages with policymakers, AMR stakeholders, and national and local AMR Coordinating Committees, including at the Regional Quadripartite and Africa CDC. Tracie coordinates in-country projects in Africa which are implementing National Action Plans on AMR.They were in conversation with Shobha Shukla, Chairperson of Global AMR Media Alliance (GAMA) and CNS Executive Director.Background piano music credit: Ms Reya Shukla Iyer and Tara Shukla Iyer.Listen to this podcast on Apple Podcasts, Amazon Music, Spotify, YouTube Podcasts, TuneIn, Podtail, ListenNotes, CastBox FM, Ivy FM, Player FM, iVoox, and other podcast streaming platforms.ThanksCNS and GAMA team

Lessons from Rwanda's Marburg Virus Outbreak and Building Resilient Systems in Global EM. Hosts: Tsion Firew, MD Brian Gilberti, MD https://media.blubrry.com/coreem/content.blubrry.com/coreem/Marburg_Virus.mp3 Download Leave a Comment Tags: Global Health, Infectious Diseases Show Notes Context and the Rwanda Marburg Experience The Threat: Marburg Virus Disease is from the same family as Ebola and has historically had a reported fatality rate as high as 90%. The Outbreak (Sept. 2024): Rwanda declared an MVD outbreak. The initial cases involved a miner, his pregnant wife (who fell ill and died after having a baby), and the baby (who also died). Healthcare Worker Impact: The wife was treated at an epicenter hospital. Eight HCWs were exposed to a nurse who was coding in the ICU; all eight developed symptoms, tested positive within a week, and four of them died. The Turning Point: The outbreak happened in city referral hospitals where advanced medical interventions (dialysis, mechanical ventilation) were available. Rapid Therapeutics Access: Within 10 days of identifying Marburg, novel therapies (experimental drugs and monoclonal antibodies) and an experimental vaccine were made available through diplomacy with the US government/CDC and agencies like WHO, Africa CDC, CEPI and more. The Outcome: This coordinated effort—combini...

Send us a textIn this conversation, Dr. John Nkengasong of the Mastercard Foundation and former PEPFAR and Africa CDC lead, discusses the evolution of public health in Africa, highlighting Rwanda's leadership in health financing and his own journey through various roles in public health. He emphasizes the need for a new public health order in Africa, focusing on domestic financing, the importance of political will, and the role of young people in shaping the future of health on the continent. The discussion also addresses the challenges facing global health financing and the interconnectedness of health, economics, and security.Support Dr. Amoako's Pediatric Cancer Project in Ghana: https://www.gofundme.com/f/help-ghanaian-children-fight-cancer-close-to-homeTo support us, consider becoming a paid subscriber on Patreon or making a one-time donation via PayPal. Subscribe to our weekly newsletter: globalhealthunfiltered.comFollow us on X (@unfiltered_gh), LinkedIn, Instagram, and TikTok.

Send us a textDrug-resistant germs are hidden killers in more than one way. Not only are the microbes invisible to the human eye, in many places, they're invisible because people simply are not looking for them systematically.Doctors often do not know what infections their patients have and treat them based on best guesses, which allows for ineffective treatments and exacerbates drug resistance. Policymakers don't know which infections are most common among populations and cannot make informed decisions about needed treatments or vaccines.This is a major problem across Africa and a new report shows just how complex the problem is.The Mapping AMR and Antimicrobial use Partnership (MAAP), which included the One Health Trust as well as the African Society for Laboratory Medicine; Africa CDC; the East, Central, and Southern Africa Health Community; Innovative Support to Emergencies, Diseases, and Disasters, a nonprofit focused on technology and communication;  the clinical research group IQVIA; and the West African Health Organization, collected data from laboratories from 14 countries in Africa (Burkina Faso, Cameroon, Gabon, Ghana, Kenya, Eswatini, Malawi, Nigeria, Senegal, Sierra Leone, Tanzania, Uganda, Zambia, and Zimbabwe). “The study revealed significant gaps in bacteriology testing capacities,” the group, whose work was paid for by the UK government's Fleming Fund, wrote in PLoS Medicine.It's the biggest survey yet of testing for antimicrobial resistance – AMR or drug resistance – in Africa.Among the gaps: too little testing overall, a lack of laboratory capacities, and poor coordination and analysis of records. Many records were kept only on paper, which made them almost impossible to access.None of this surprises Dr. Sabiha Essack, South African Research Chair in Antibiotic Resistance and One Health and Professor in Pharmaceutical Sciences at the University of KwaZulu-Natal. In an ideal world, she says, a doctor, nurse or other professional should see a patient, test them to see what specific microbe is causing an infection, check to see which drugs will successfully fight that germ, and then treat the patient accordingly.Cheap point-of-care tests should be available everywhere and the results of those tests should be entered into systems that officials can use to make policy decisions, she says. Listen as she tells One World, One Health host Maggie Fox other ways to improve our knowledge about the drug-resistant infections that lurk out there. Want to know more? You can find One World, One Health episodes on drug-resistant infections in cancer patients; superbugs and microplastics; the personal toll of antibiotic resistance; one woman's antibiotic resistance nightmare; how to prevent drug resistance, and more.

From climate change and conflict to economic instability, today's converging global crises are reshaping the landscape of child health. In this episode, host Garry Aslanyan  speaks with two leading voices in global health: Landry Tsague, Director of the Center for Primary Health Care at Africa CDC, and Debra Jackson, Takeda Chair in Global Child Health at the London School of Hygiene & Tropical Medicine. They share insights on what should be done to strengthen health systems, empower communities and create conditions where children not only survive, but thrive amid the turbulence of the metacrisis.Related episode documents, transcripts and other information can be found on our website.Subscribe to the Global Health Matters podcast newsletter.  Follow us for updates:@TDRnews on XTDR on LinkedIn@ghm_podcast on Instagram@ghm-podcast.bsky.social on Bluesky Disclaimer: The views, information, or opinions expressed during the Global Health Matters podcast series are solely those of the individuals involved and do not necessarily represent those of TDR or the World Health Organization.  All content © 2025 Global Health Matters.  

Millions of us take aspirin daily to ward off heart attack or stroke, but a new study has found an alternative blood thinner, clopidogrel, could be more effective. We find out how it compares.An oral health check-up at least two weeks before surgery has shown to reduce the risk of post-operative infections such as pneumonia as well as reduce the length of a patients' hospital stay. Dr Kristina Wanyonyi-Kay Research Programme Leader at The Healthcare Improvement Studies Institute at the University of Cambridge assesses what this Japanese study tells is about the connection between oral health and the rest of our bodies.The Africa CDC and WHO have just launched ambitious targets to cut Cholera by 90% across Africa. Global health journalist Andrew Green assesses if this target is likely to be met with the measures proposed.We meet a Chilean football team who've all had organ transplants. They're trying to raise awareness and improve the number of donors in the country. Our reporter Jane Chambers went to Santiago to find out more.Could music help or worsen travel sickness? A study in China found happy music improved symptoms whilst sad music made them worse.Presenter: Claudia Hammond Producers: Katie Tomsett & Hannah Robins

The public health systems in Africa are under growing pressure. The sharp 70% drop in official development assistance (ODA) risks weakening critical health programmes, while a rise in public health emergencies continues to stretch already fragile infrastructure.   The Africa Centres for Disease Control and Prevention (Africa CDC) – the public health agency of the African Union – recognises that these are not isolated challenges. They present a fundamental threat to Africa's political, social, and economic resilience, with far-reaching implications to global stability.   In this episode, Dr Jean Kaseya, Director General at the Africa CDC, discusses the agency's mandate to support AU member states in advancing public health priorities and strengthening the capacity of national health institutions to respond to disease threats.  Related content:  The global response to the mpox outbreak in Africa will show if lessons from COVID-19 have been learned A fair pandemic treaty is unlikely, but poorer countries have healthy options Africa's Health Financing in a New Era – April, 2025

Africa is undergoing a health funding crisis due to overreliance on external aid and a lack of internal investment from African governments. The healthcare sector is 95 percent dependent on external aid for crucial commodities: vaccines, medication, and diagnostic equipment. Africa saw a 41 percent rise in public health emergencies in 2024, highlighting the vulnerability of the health infrastructure. In response to these challenges, the Africa Center for Disease Control (CDC) released a concept paper titled: Africa's Health Financing in a New Era. In this concept paper, the Africa CDC introduces innovative financing measures to bridge the funding gap.  Mvemba is joined by Dr. Jean Kaseya, Director-General of the Africa CDC, to discuss the importance of good governance, private sector investment, and strategic planning in strengthening Africa's domestic resource mobilization.

Cuts to aid budgets are having a huge impact on the delivery of healthcare in Africa, the Forum's Lora du Moulin tells Radio Davos. And the head of Africa Centres for Disease Control and Prevention, Jean Kaseya, says why tech and regional collaboration give him hope for the future of the continent and the health of its people. Links: World Economic Forum Centre for Health and Healthcare: https://centres.weforum.org/centre-for-health-and-healthcare/home Africa Centres for Disease Control and Prevention: https://africacdc.org/ Regionalized Vaccine Manufacturing Collaborative: https://rvmc.net/ Check out all our podcasts on wef.ch/podcasts:  YouTube: https://www.youtube.com/@wef Radio Davos - subscribe: https://pod.link/1504682164 Meet the Leader - subscribe: https://pod.link/1534915560 Agenda Dialogues - subscribe: https://pod.link/1574956552 Join the World Economic Forum Podcast Club: https://www.facebook.com/groups/wefpodcastclub

Vaccinations play an important role in both our individual and community health. They help to prevent serious and sometimes deadly diseases by strengthening our immune system. But in recent years this cost effective method of disease prevention has come under the spot light, drawing attention to some myths and misconceptions. In this episode, Dr Anne von Gottberg dives into the importance of vaccinations, how to handle missed vaccines, vaccine dos and don'ts and recent changes in the Extended Programme onIimmunzation(EPI) in South Africa.About our Guest: Dr Anne von Gottberg is currently the laboratory lead at the Centre for Respiratory Diseases and Meningitis at the National Institute for Communicable Diseases, Johannesburg, South Africa; and Associate Professor within the School of Pathology, Faculty of the Health Sciences, University of the Witwatersrand, Johannesburg; and Honorary Professor, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town. She leads a laboratory team responsible for reference diagnostics for respiratory and meningitis pathogens nationally and regionally. The laboratory is the regional reference laboratory for the World Health Organization (WHO) Vaccine-preventable Invasive Bacterial Diseases (VP-IBD) Coordinated Global Surveillance Network for the southern African region; a National Influenza Centre (NIC); and a global WHO RSV and regional SARS-CoV-2 reference laboratory. She is currently a member of several committees and technical advisory groups for AFRO, Africa CDC and WHO. Her main interests include surveillance for meningitis and respiratory pathogens, assessing vaccine effectiveness where relevant. She has authored or co-authored more than 200 articles in peer-reviewed journals. In addition, she supervises a number of Masters and PhD students. Dr von Gottberg obtained her MBBCh and PhD at the University of the Witwatersrand, and trained for her specialisation in clinical microbiology (FC Path[SA] MICRO) at the National Health Laboratory Service (former South African Institute for Medical Research) and at the University of the Witwatersrand.WE'D LOVE YOUR FEEDBACK ON THIS EPISODE – Visit the Microbe Mail website to sign up for updates Follow on:Instagram: Microbe_MailX/Twitter: @microbemailFacebook: MicrobeMailTiktok: @microbe.mailWatch this episode on our new YouTube channel: Microbe MailE-mail us: mail.microbe@gmail.com

Africa's Center for Disease Control and Prevention – Africa CDC – says it is battling to identify a new disease in the Democratic Republic of Congo that has claimed at least 79 lives and infected hundreds more. Columbus Mavhunga reports from Zimbabwe's capital, where the Southern African Association of Doctors for Human Rights is calling for a regional approach to stop the disease from spreading to other countries

Send us a textSmallpox may be gone but it's got a cousin called mpox, and that virus is now spreading fast across parts of Africa.As of October 2024, this mpox outbreak had infected more than 40,000 people, mostly in the Democratic Republic of Congo, according to the Africa Centres for Disease Control and Prevention. More than 1,000 people have died from the infection. The World Health Organization (WHO) declared mpox in the Democratic Republic of Congo and neighboring countries to be a Public Health Emergency of International Concern in August 2024.Officials are distributing smallpox vaccines to try to control it. The viruses are closely enough related so researchers believe that modern smallpox vaccines can protect people safely against mpox. But the rollout is slow.  It's not clear why the virus has started spreading in households, but it's infecting and killing more and more children.To make matters worse, people are desperate for medicines to prevent infection and help treat symptoms, which include fevers and a rash. They're seeking antibiotics, which cannot treat a virus. This inappropriate use of antibiotics can drive drug resistance.This is the second time mpox has been declared a public health emergency by the WHO since 2022. A slightly different strain of mpox has been spreading since then through close contact, often sexual and often among men who have sex with men. Mpox is even now showing up in new cities and countries in North America and Europe.Nodar Kipshidze, Senior Research Analyst at the One Health Trust, says the virus spreads easily because people often don't know they have it. It's also not clear where it originally came from, although small rodents and other mammals can spread it. In this episode of One World, One Health, Nodar tells us mpox is causing a lot of confusion, and we need to ensure we learn from previous outbreaks and share resources globally to stop the spread and save lives.

A new study from America looks at the safety of organ transplants between people with HIV. Its promising results raise the potential for expanding access to life-saving treatments.This week's show also examines a surprising resurgence of scurvy, a disease often associated with historical poverty. Is the current cost of living crisis contributing to nutritional deficiencies? Plus, an update from the Africa CDC reveals encouraging news about the Marburg virus outbreak, but a grim warning about the spread of Mpox. Presenter: Claudia Hammond Producer: Margaret Sessa Hawkins

Nidhi Bouri, DAA at USAID Bureau for Global Health, joined us to speak to the U.S. response to the dangerous mpox outbreak (clade 1b) centered in the Democratic Republic of Congo, boosted by President Biden's commitment at UNGA to $500m in support, including 1 million vaccine doses. Much better data is urgently needed on the needs for diagnostics and vaccines. Tensions remain high among Africa CDC, WHO, and other key institutions with proven response capability, most notably Gavi, UNICEF and the Global Fund. Much is not known about modes of transmission, and the durability and efficacy of the Jynneos vaccine for clade 1b. As the virus inevitably lands in the United States, communications will be critical. Some important progress was seen in the High Level Meeting on anti-microbial resistance. The Marburg outbreak in Rwanda is of acute concern for multiple reasons: no vaccine, little testing, little knowledge of the pattern of spread. It is crunch time, as multiple replenishments converge. “Let's be clear, there is not enough money.”

On Daybreak Africa: Head of the African Union's health watchdog said it was time for the West to show it had learned from the Covid pandemic and not abandon Africa during the mpox outbreak. Plus, the US proposes two new permanent seats on the UN Security Council for Africa. A new report says if the Islamic State Somalia branch has become a financial hub, its leader may become overall chief of the IS. Kenyan President William Ruto visits Germany. Senegalese President Bassirou Diomaye Faye dissolves the National Assembly and calls for new legislative elections on November 17. As the gender gap among voters widens, will women push Kamala Harris to victory in the US election. For this and more tune in to Daybreak Africa!

This week's conversation focuses on the current spread of M-Pox (formerly Monkeypox) in Africa and the response to the outbreak. Dr. Boghuma Titanji, an infectious disease expert at Emory University, discusses the history of M-Pox outbreaks in Africa and the factors contributing to its spread. The conversation also explores the role of African governments, the Africa CDC, and the international community in addressing the outbreak. The need for increased investment in healthcare, research, and development in Africa is highlighted, as well as the importance of holding governments accountable and promoting grassroots education on healthcare funding. The conversation explores the challenges and potential solutions for Africa to produce its own vaccines and medications, emphasizing the untapped potential of the continent. It highlights the low percentage of vaccines and basic drugs manufactured in Africa and the competition with established manufacturing hubs in other countries. Trust in locally produced vaccines is also discussed, with the need to shift the mindset of consumers. The conversation emphasizes addressing infrastructure and resource limitations before focusing on vaccine production. Considering the different transmission patterns and populations affected, the need for a tailored vaccination approach for M-POX outbreaks is highlighted. Exciting developments in infectious disease research and vaccine trials in Africa are also mentioned.00:00 The Current Spread of M-pox in Africa14:20 The Response to the M-pox Outbreak19:00 Underlying Issues: Lack of Investment and Prioritization23:21 The Role of Global Solidarity in Public Health25:45 Accountability and Self-Reliance in Healthcare29:35 Accountability and Local Ownership37:47 The Role of the Private Sector in Vaccine Production50:26 Tailoring Vaccination Strategies55:20 Promising Developments in Infectious Disease ResearchFollow Boghuma Titanji on LinkedInTo support us, consider becoming a paid subscriber on Patreon or making a one-time donation via PayPal.Follow us on X (@unfiltered_gh), LinkedIn, Instagram, and TikTok.

A fall in Chinese producer prices has fuelled concerns grow that deflation may be taking hold in the world's second-largest economy. Industrial producer prices fell 1.8 per cent in August, the most in four months. Steel and agriculture were among the sectors hit. Meanwhile, consumer prices rose 0.6 per cent.In Africa, the Africa CDC and WHO have launched a $600 million plan to combat mpox in 14 countries from September 2024 to February 2025. The initiative focuses on improving surveillance, laboratory detection, case management, infection prevention, and vaccination efforts to strengthen public health responses across the continent.Apple's iPhone 16 series, made in India, will be globally available shortly after its sales launch, marking a milestone for India's manufacturing sector and the Make-in-India initiative.

The mpox case surge in Africa has been declared a Public Health Emergency of International Concern (PHEIC) by the WHO. A new clade of the virus has emerged since the 2022 outbreak which has led to a rapid increase in cases. Professor Salim Abdool Karim, who is the the chair of the Africa CDC's Emergency Consultative Group and the director of CAPRISA, the Center for the AIDS Programme of Research in South Africa, joins Gavin Cleaver and Maneet Virdi to lay out in clear terms what's happening in Africa, what the PHEIC means, and what the future could look like.Send us your feedback!Continue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

Quinze jours après que l'OMS a déclenché son plus haut degré d'alerte face à la résurgence des cas de Mpox en Afrique, l'épidémie continue de progresser sur le continent. La RDC reste de loin le pays le plus touché, mais l'épidémie s'étend. Treize autres pays présentent désormais des cas suspects. Plusieurs États ont promis d'envoyer prochainement des doses de vaccins. Quand ces doses seront-elles livrées ? En quelles quantités ? À quand la fabrication de vaccins sur le continent ? Entretien avec Jean Kaseya, le directeur général d'Africa CDC, le Centre de contrôle et de prévention des maladies de l'Union africaine. RFI : le Mpox poursuit sa progression sur le continent. L'Africa CDC fait état de près de 23 000 cas suspects détectés au 27 août et plus de 600 décès. Est-ce que ces chiffres vous inquiètent ?Jean Kaseya : Ces chiffres m'inquiètent au plus haut point, puisque ça prouve ce que nous disons tous les jours, que nous avons plusieurs épidémies Mpox en une. Pourquoi nous le disons, c'est puisque nous avons quatre variants qui se côtoient aujourd'hui en Afrique et qui ont des épidémiologies différentes, qui ont des symptomatologies qui se présentent dans les différents groupes d'âges et qui aujourd'hui n'ont pas suffisamment de recul en termes de médicaments et en termes de mesures applicables comme les vaccins et autres. Donc, ça m'inquiète au plus haut point.La RDC reste, et de loin, le pays le plus touché. Est-ce que c'est là où la progression est la plus forte ces derniers jours ?La progression est forte dans plusieurs provinces de la RDC. Mais la progression, on la voit aussi dans d'autres pays africains comme le Burundi, comme la RCA. Mais je dois dire, ce qui m'inquiète le plus, c'est que nous avons des pays qui sont non endémiques, mais qui ont rapporté pour la première fois des cas de Mpox comme le Gabon. Le ministre de la Sierra Leone m'informait aujourd'hui [mercredi 28 août], qu'il a eu un cas qui lui semble patent pour Mpox. Mais comme la Sierra Leone n'a pas de laboratoire fiable, il ne peut pas confirmer cela. Et donc moi, je considère, sur base de la symptomatologie, sur base de l'histoire de la maladie, que c'est un cas suspect de Mpox. Et je classe la Sierra Leone maintenant comme un nouveau pays qui est le 14e pays affecté par le Mpox.Plusieurs pays ont promis d'envoyer des doses de vaccin au continent. Quelle sera l'ampleur de ces livraisons ?Je voudrais reconnaître l'effort que les partenaires d'Afrique ont fait pour jusque-là, sécuriser les vaccins que nous avons. Nous avons d'abord, avec la branche humanitaire de l'Union européenne, sécurisé 215 000 doses. À cela s'ajoute les 100 000 doses que la France vient de donner par le même mécanisme de l'Union européenne et Africa CDC. En plus, nous avons 100 000 doses qui viendront de l'Allemagne. Mais je dois saluer le gouvernement espagnol, puisque l'Espagne donne 500 000 doses de vaccins. À ces doses-là qui représentent à peu près 1 million de doses, nous savons que Gavi est aussi en train de travailler avec nous, pour disponibiliser autour de 500 000 doses. Donc, nous pouvons dire qu'à ce stade, nous partons déjà autour de 1,5 ou 1,6 million de doses, sur les 10 millions que nous voulons avoir.À quelle échéance ces doses seront-elles livrées au continent ?Les vaccins que nous avons déjà eus, par exemple les 215 000 doses sont disponibles même à partir de demain. Ce que nous voulons, avant que les vaccins arrivent aux pays, c'est qu'il y ait une bonne logistique qui soit en place. Donc, je suis en train d'espérer et de travailler, comme je pense que le niveau de préparation des pays est assez optimal, que la semaine prochaine, les premières doses des vaccins sécurisés par Africa CDC, dans le mécanisme que nous avons mis en place, vont atterrir dans les différents pays.Mais combien de doses, précisément, pourraient arriver dès la semaine prochaine ?Nous allons commencer graduellement, et ça, c'est important que la population africaine le sache : nous avons décidé, à Africa CDC, de faire en sorte que ce qui s'est passé avec le Covid n'arrive plus. Donc, l'accord que nous avons avec la société Bavarian Nordic qui produit ces vaccins, c'est que cette année, ils vont nous donner 3 millions de doses. Mais ils vont aussi faire le transfert des technologies pour que ce vaccin soit produit sur le continent africain, par les compagnies africaines. Nous avons déjà un accord et nous avons déjà sélectionné la société qui pourrait faire cette production. Nous pensons que d'ici février, la société africaine qui a été sélectionnée sera en mesure d'inonder le marché africain avec le vaccin Mpox.À lire aussiMpox: pourquoi l'accès aux vaccins est problématique en Afrique?

This week the Africa Centres for Disease Control and Prevention and the World Health Organization both declared mpox as a public health emergency. This is the first time the Africa CDC declared a public health emergency as it aims to increase its autonomy. There have been more than 17,000 suspected cases across the African continent, more than the total number of cases reported in 2023. In the United Kingdom, the International Rescue Committee is set to shed 1 in 9 staff as it faces a funding crisis. We explore the wider issue of reduced funding in global development despite rising humanitarian needs. To discuss these stories, and others, Devex President and Editor-in-Chief Raj Kumar sits down with Managing Editor Anna Gawel and Business Editor David Ainsworth for the latest episode of the podcast series. Sign up to the Devex Newswire and our other newsletters: https://www.devex.com/account/newsletters

“It's a clarion call to action. It's a recognition that we can no longer afford to be reactive. We must be proactive and aggressive in our effort to eliminate this threat.” Africa's leading health body - Africa CDC – has declared the rapidly rising cases of Mpox in East Africa a public health emergency. Since the beginning of the year, nearly 14,000 cases and 450 deaths have been recorded in the Democratic Republic of Congo, the most affected country. And more cases are being recorded in other African countries - including a number, like Uganda and Kenya, which are seeing the disease for the first time. So what should the global response be to what's been called the ‘most dangerous' strain of the disease yet? Presenter: Alan KasujjaGuests: Dr Jean Claude Udahemuka of the University of Rwanda and Dr Matshidiso Moeti - WHO Regional Director for Africa.

The European Parliamentary elections will take place next month, and with anti-aid and anti-migrant parties poised to make big gains, there are fears for the future of the world's second-largest development budget. According to one senior Brussels politician, the controversial swiping of €2 billion from the development pot to fund a crackdown on illegal migration could just be the start of the European Union's reduced focus on supporting global development initiatives. We explore how Europe's political landscape is changing, as well as what it could mean to the EU's approach to foreign assistance. In South Africa, we found that the country's politics is preventing NGOs from effectively delivering health services to refugees and migrants. Aid groups and civil society organizations are trying to untangle the snarled problem of how to guarantee access to health services for all people who are far from home — whether that home is in another country or somewhere else in South Africa — without creating disparities in health care services that enrage local communities. On the topic of the continent, Devex obtained a copy of an African Union audit that examined accusations against Africa Centres for Disease Control and Prevention's Director General Dr. Jean Kaseya. The audit, which was finalized in March, analyzed over a dozen allegations in a February whistleblower email. We dig into the claims, including allegations of misusing funds, flouting rules, and exhibiting favoritism, among others. For the latest episode of our podcast series, Devex President and Editor-in-Chief Raj Kumar sits down with Managing Editor Anna Gawel and Senior Reporter Sara Jerving to discuss these stories and others. Sign up to the Devex Newswire and our other newsletters: https://www.devex.com/account/newsletters

Host Javier Guzman launches Season 2 with reflections on global progress on preparedness since the pandemic, then speaks with H.E. Dr. Jean Kaseya of Africa CDC about how Africa CDC is translating lessons from COVID-19 into stronger, more resilient systems.

This week we published an article on how USAID spent its money last year. We noted that the agency spent $38.1 billion through its assistance and acquisition mechanism in the fiscal year that ended in September 2023. From the data it is evident that USAID has increased its spending for humanitarian crises, including the war in Ukraine. The Africa Centres for Disease Control and Prevention released their wishlist for the pandemic treaty. However, with countries in the global north — including the United Kingdom, Germany, and France — slashing their aid budgets, questions are being raised about whether there is an appetite for another pandemic financing mechanism, which is among one of the agency's asks. On the topic of the Africa CDC, its acting deputy director-general, Dr. Ahmed Ogwell Ouma, is resigning from the organization this month as he wasn't allowed to apply for the deputy director-general position due to country quotas. Dr. Raji Tajudeen will become the acting deputy director-general until a formal appointment is made. To dig into these stories and others, Devex President and Editor-in-Chief Raj Kumar sits down with Patrick Fine from Brookings and Devex Associate Editor Rumbi Chakamba for the latest episode of our weekly podcast series. Sign up to the Devex Newswire and our other newsletters: https://www.devex.com/account/newsletters

Southern Africa Development Community (SADC) health ministers have refused to accept a proposal by the Africa Center for Disease Control to declare cholera a public health emergency in SADC member countries. This, as cholera has affected nearly 15 member states, according to the Lusaka Times. Khumbize Kandodo Chiponda, Malawi's health minister, tells VOA's James Butty, the Africa CDC needs to develop guidelines because cholera's impact varies from country to country.

In this episode, we have the privilege of hosting Dr. Mosoka Fallah, a distinguished figure in the field of public health in Africa. Dr. Fallah has been a leading force in combatting infectious disease outbreaks across the continent. Notably, his remarkable efforts in mobilizing local communities in Liberia during the 2013-2015 Ebola outbreak earned him recognition as one of Time Magazine's Persons of the Year in 2014. Currently, Dr. Fallah serves as the program manager for Africa CDC's "Saving Lives and Livelihoods" initiative, a groundbreaking $1.5 billion partnership with the Mastercard Foundation. This initiative is dedicated to promoting vaccine equity in Africa by supporting vaccine distribution, manufacturing, and bolstering the region's public health infrastructure. During our conversation, Dr. Fallah provides insights into the progress of the "Saving Lives and Livelihoods" initiative to date, shedding light on the pivotal role that digital health and technology play in enabling the initiative to reach its ambitious objectives. For more information about the "Saving Lives and Livelihoods" initiative, please visit: https://africacdc.org/saving-lives-and-livelihoods/ MedxTek Africa is produced and hosted by Dr Sam Oti, and co-edited by Veronica Ojiambo. If you have any thoughts on this episode, or recommendations of African health innovators that you'd like us to host on the show, please reach out directly by email: sam.oti@alumni.harvard.edu or find us on Twitter or LinkedIn. Please note that the MedxTek Africa Podcast is distinct from Dr. Oti's role as a Senior Program Specialist at Canada's International Development Research Centre. The information provided in this podcast is not medical advice, nor should it be construed or applied as a replacement for medical advice. The MedxTek Africa Podcast, its production team, guests and partners assume no liability for the application of the podcast's content.

Jean-Philbert Nsengimana is Africa CDC's Chief Digital Advisor. He is also a former minister of ICT in Rwanda. In this episode, Phil shares Africa CDC's vision for digitally transforming Africa's public health systems. Among other things, we talk about Africa CDC's inaugural digital transformation strategy which will be launched on March 6, 2023 at the Africa Health Agenda International Conference (AHAIC 2023) in Kigali. For more information about AHAIC 2023, please visit: https://ahaic.org/ MedxTek Africa is produced and hosted by Dr Sam Oti, and co-edited by Veronica Ojiambo. If you have any thoughts on this episode, or recommendations of African health innovators that you'd like us to host on the show, please reach out directly by email: sam.oti@alumni.harvard.edu or find us on Twitter or LinkedIn. Please note that the MedxTek Africa Podcast is distinct from Dr. Oti's role as a Senior Program Specialist at Canada's International Development Research Centre. The information provided in this podcast is not medical advice, nor should it be construed or applied as a replacement for medical advice. The MedxTek Africa Podcast, its production team, guests and partners assume no liability for the application of the podcast's content.